Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 319

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis

Généreux, Philippe, Schwartz, Allan, Oldemeyer, J. Bradley, Pibarot, Philippe, Cohen, David J., Blanke, Philipp, Lindman, Brian R., Babaliaros, Vasilis, Fearon, William F., Daniels, David V., Chhatriwalla, Adnan K., Kavinsky, Clifford, Gada, Hemal, Shah, Pinak, Szerlip, Molly, Dahle, Thom, Goel, Kashish, O’Neill, William, Sheth, Tej, Davidson, Charles J., Makkar, Raj R., Prince, Heather, Zhao, Yanglu, Hahn, Rebecca T., Leipsic, Jonathon, Redfors, Björn, Pocock, Stuart J., Mack, Michael, Leon, Martin B. · 2025 · New England Journal of Medicine

Abstract

BACKGROUND: For patients with asymptomatic severe aortic stenosis and preserved left ventricular ejection fraction, current guidelines recommend routine clinical surveillance every 6 to 12 months. Data from randomized trials examining whether early intervention with transcatheter aortic-valve replacement (TAVR) will improve outcomes in these patients are lacking. METHODS: At 75 centers in the United States and Canada, we randomly assigned, in a 1:1 ratio, patients with asymptomatic severe aortic stenosis to undergo early TAVR with transfemoral placement of a balloon-expandable valve or clinical surveillance. The primary end point was a composite of death, stroke, or unplanned hospitalization for cardiovascular causes. Superiority testing was performed in the intention-to-treat population. RESULTS: A total of 901 patients underwent randomization; 455 patients were assigned to TAVR and 446 to clinical surveillance. The mean age of the patients was 75.8 years, the mean Society of Thoracic Surgeons Predicted Risk of Mortality score was 1.8% (on a scale from 0 to 100%, with higher scores indicating a greater risk of death within 30 days after surgery), and 83.6% of patients were at low surgical risk. A primary end-point event occurred in 122 patients (26.8%) in the TAVR group and in 202 patients (45.3%) in the clinical surveillance group (hazard ratio, 0.50; 95% confidence interval, 0.40 to 0.63; P<0.001). Death occurred in 8.4% of the patients assigned to TAVR and in 9.2% of the patients assigned to clinical surveillance, stroke occurred in 4.2% and 6.7%, respectively, and unplanned hospitalization for cardiovascular causes occurred in 20.9% and 41.7%. During a median follow-up of 3.8 years, 87.0% of patients in the clinical surveillance group underwent aortic-valve replacement. There were no apparent differences in procedure-related adverse events between patients in the TAVR group and those in the clinical surveillance group who underwent aortic-valve replacement. CONCLUSIONS: Among patients with asymptomatic severe aortic stenosis, a strategy of early TAVR was superior to clinical surveillance in reducing the incidence of death, stroke, or unplanned hospitalization for cardiovascular causes. (Funded by Edwards Lifesciences; EARLY TAVR ClinicalTrials.gov number, NCT03042104.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa2405880

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 319

Metadata

Authors
Généreux, P., Schwartz, A., Oldemeyer, J. B., Pibarot, P., Cohen, D. J., Blanke, P., Lindman, B. R., Babaliaros, V., Fearon, W. F., Daniels, D. V., Chhatriwalla, A. K., Kavinsky, C., Gada, H., Shah, P., Szerlip, M., Dahle, T., Goel, K., O’Neill, W., Sheth, T., Davidson, C. J., Makkar, R. R., Prince, H., Zhao, Y., Hahn, R. T., Leipsic, J., Redfors, B., Pocock, S. J., Mack, M., & Leon, M. B.
Venue
New England Journal of Medicine
Published
2025-01-16
Volume
392
Issue
3
Pages
217-227
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4403812729
Cited by
319
References
22
FWCI
85.69
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis. https://app.cochat.ai/papers/10.1056/nejmoa2405880
The paper
Généreux, P., Schwartz, A., Oldemeyer, J. B., Pibarot, P., Cohen, D. J., Blanke, P., Lindman, B. R., Babaliaros, V., Fearon, W. F., Daniels, D. V., Chhatriwalla, A. K., Kavinsky, C., Gada, H., Shah, P., Szerlip, M., Dahle, T., Goel, K., O’Neill, W., Sheth, T., . . . Leon, M. B. (2025). Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2405880

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.